Skip to main content
Fig. 1 | Clinical and Translational Medicine

Fig. 1

From: Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes

Fig. 1

Nanotrapping exosomes from tissue culture supernatants. a CD63, Alix, and Actin levels from exosomes nanotrapped by either NT80 + 82 particles (lanes 3 and 4) or by NT86 particles (Ctrl NT 86; lanes 5 and 6) from Jurkat (HTLV-1 uninfected) and HUT102 (HTLV-1 infected) tissue culture supernatants were analyzed by Western blot. MT-2 whole cell extracts and molecular weight (MW) ladder are shown (lanes 1 and 2). b CD81 ELISA signals were measured from isolated exosomes as a measure of exosome concentration. Exosomes were nanotrapped (designated by NT) from HTLV-1 negative Jurkat, and HTLV-1 infected C8166 and HUT102 cells from 1 mL of starting tissue culture supernatant. The background is designated as blank. Ultracentrifuged Jurkat exosomes (ultra Jurkat exos) were also measured. Statistical analysis was performed by unpaired t-test. ns not significant; *p-value < 0.05; **p-value < 0.01 (n − 4). c Measurement of acetylcholinesterase (AchE) activity associated with exosome populations was performed. Tissue culture supernatant was measured for AchE activity from Jurkat, C8166 (C81), MT-2, and HUT102 cells both prior to nanotrapping (blue) and after addition of NT80 + 82 and subsequent exosome isolation (orange). d Tissue culture supernatants from HTLV-1 infected cells were analyzed by specialized flow cytometry for NanoFACS. Left panel represents a representative sample prior to addition of Nanotrap® particle (Pre-NT), middle panel represents sample with addition of Nanotrap® particle (+NT) and right panel represents sample after Nanotrap® particle and exosomes have been removed (Post NT). NTs are shown circled in green, while 100 nm vesicles are circled in red, and noise is circled in yellow

Back to article page